Cao Xincen, Chen Liang
Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Zhongguo Fei Ai Za Zhi. 2023 Nov 20;26(11):851-862. doi: 10.3779/j.issn.1009-3419.2023.102.41.
Lung cancer is one of the malignant tumors with the highest incidence and mortality rate in China, and its occurrence and development mechanism and treatment methods are the current research focuses. In recent years, the emergence of drugs targeting various tumor driver genes has significantly improved patients' survival and quality of life, setting off a wave of research on new therapeutic targets. Among them, long non-coding RNA (lncRNA) plays a crucial role in the malignant behavior of tumors, which has attracted widespread attention. Shown by a large number of studies, partial members of lncRNA small nucleolar RNA host gene (SNHG) family are aberrantly expressed in many maliglant tumors including non-small cell lung cancer (NSCLC) and participate in cell proliferation, invasion and migration, which may act as a new diagnostic and prognostic biomarker and can be a therapeutic target of NSCLC. In this review, we comprehensively summarize and explore the recent investigation of SNHGs in NSCLC in order to provide new ideas for the diagnosis and treatment of NSCLC. .
肺癌是我国发病率和死亡率最高的恶性肿瘤之一,其发生发展机制及治疗方法是当前的研究重点。近年来,针对各种肿瘤驱动基因的药物的出现显著提高了患者的生存率和生活质量,掀起了一股新治疗靶点的研究热潮。其中,长链非编码RNA(lncRNA)在肿瘤的恶性行为中起关键作用,这已引起广泛关注。大量研究表明,lncRNA小核仁RNA宿主基因(SNHG)家族的部分成员在包括非小细胞肺癌(NSCLC)在内的许多恶性肿瘤中异常表达,并参与细胞增殖、侵袭和迁移,其可能作为一种新的诊断和预后生物标志物,且可成为NSCLC的治疗靶点。在本综述中,我们全面总结并探讨了近期关于SNHGs在NSCLC中的研究,以期为NSCLC的诊断和治疗提供新思路。